Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin.

Akkol, Esra Küpeli; Tatli, Iffet Irem; Karatoprak, Gökçe Seker; Agar, Osman Tuncay; Yücel, Çigdem; Sobarzo-Sánchez, Eduardo; Capasso, Raffaele.

Afiliação

Akkol EK; Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.
Tatli II; Department of Pharmaceutical Botany, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey.
Karatoprak GS; Department of Pharmacognosy, Faculty of Pharmacy, Erciyes University, 38039 Kayseri, Turkey.
Agar OT; Department of Pharmacognosy, Faculty of Pharmacy, Süleyman Demirel University, 32200 Isparta, Turkey.
Yücel Ç; Department of Pharmaceutical Technology, Faculty of Pharmacy, Erciyes University, 38039 Kayseri, Turkey.
Sobarzo-Sánchez E; Instituto de Investigación y Postgrado, Facultad de Ciencias de la Salud, Universidad Central de Chile, Santiago 8330507, Chile.
Capasso R; Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Cancers (Basel) ; 13(11)2021 May 31.

Article em En | MEDLINE | ID: mdl-34073059